Immune cell therapy shows promise for Hard-to-Treat melanoma

This study tests a treatment that uses a patient's own immune cells (T-cells) to fight advanced melanoma. Some participants also receive a dendritic cell vaccine to boost the immune response. The goal is to see if the T-cells last longer and work better against the cancer. The trial includes several groups exploring different ways to give the therapy, including directly into the spinal fluid for brain involvement.